Capnia

Capnia is a startup based in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Capnia develops the CoSense® ETCOc Monitor, a non-invasive medical device that measures end-tidal carbon monoxide in newborns' breath to detect and monitor hemolysis, enabling improved management of neonatal jaundice and reducing the risk of bilirubin neurotoxicity.